Bright Minds Biosciences (DRUG) Change in Cash (2020 - 2026)
Bright Minds Biosciences (DRUG) reported Change in Cash of $159.9 million for Q1 2026, up 10526.73% on a YoY basis from N/an in Q1 2025, and up 2842.94% quarter-over-quarter from $5.4 million in Q4 2025.
Bright Minds Biosciences (DRUG) Change in Cash (2020 - 2026) Analysis & Trends
Bright Minds Biosciences has reported Change in Cash for 7 years, with the latest figure at $159.9 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash rose 10526.73% year-over-year to $159.9 million; the trailing twelve-month figure through Mar 2026 stood at $186.0 million (up 439.97% YoY), and the FY2025 full-year result was $55.9 million, up 7429.91% from the prior year.
- Change in Cash for Q1 2026 stood at $159.9 million, up from $5.4 million in the prior quarter.
- The five-year high for Change in Cash was $159.9 million in Q1 2026, with the low at -$15.1 million in Q3 2022.
- Historically, Change in Cash has averaged $12.1 million across 5 years, with a median of $159537.1 in 2024.
- Annual changes were most pronounced in 2024 — Change in Cash jumped 87934.57% — and 2025, when it plunged 1692.74%.
- Bright Minds Biosciences' Change in Cash stood at -$301578.2 in 2022, then soared by 113.63% to $41101.7 in 2023, then jumped by 87934.57% to $36.2 million in 2024, then sank by 84.99% to $5.4 million in 2025, then jumped by 2842.94% to $159.9 million in 2026.
- The last three Change in Cash figures came in at $159.9 million (Q1 2026), $5.4 million (Q4 2025), and $23.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -45.97 Mn |
| 10 | Bright Minds Biosciences | 16.28 Bn | 16.22 Bn | - | 159.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 159.86 Mn |
| Dec 31, 2025 | 5.43 Mn |
| Sep 30, 2025 | 23.29 Mn |
| Jun 30, 2025 | -2.54 Mn |
| Mar 31, 2025 | -1.53 Mn |
| Dec 31, 2024 | 36.18 Mn |
| Sep 30, 2024 | -356,796.89 |
| Jun 30, 2024 | 159,537.06 |
| Mar 31, 2024 | -613,761.76 |
| Dec 31, 2023 | 41,101.67 |
| Sep 30, 2023 | -6.30 Mn |
| Jun 30, 2023 | 1.24 Mn |
| Mar 31, 2023 | 1.74 Mn |
| Dec 31, 2022 | -301,578.19 |
| Sep 30, 2022 | -15.12 Mn |
| Jun 30, 2022 | 2.24 Mn |
| Mar 31, 2022 | 2.88 Mn |
| Dec 31, 2021 | 3.83 Mn |
| Sep 30, 2021 | -1.91 Mn |
| Jun 30, 2021 | -2.86 Mn |